370 filings
Page 8 of 19
UPLOAD
b1aoqbp8gz3499xwfk99
5 Aug 20
Letter from SEC
12:00am
S-8
fnyccol208
4 Aug 20
Registration of securities for employees
5:08pm
8-K
643k1q 4pj28z3iq2344
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
8-K
bk1nj pt0
26 Jun 20
Departure of Directors or Certain Officers
4:06pm
425
i6bxz22dkxp5td
24 Jun 20
Business combination disclosure
5:11pm
8-K
y6uw5 uzf
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
crk 2na8b9v
24 Jun 20
Business combination disclosure
4:03pm
425
8xeez7
22 Jun 20
Business combination disclosure
5:30pm
8-K
5jnllw6
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
8ws7s4bnaace3umlsg
18 Jun 20
Departure of Directors or Certain Officers
4:02pm
8-K
0h1hamjdqd1ekukrq0me
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
3wej jmo5ruh7k18
22 May 20
Departure of Directors or Certain Officers
5:04pm
8-K
8of7efj6y0vaxqdzclmc
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
DEFA14A
0z0b epvgy7
29 Apr 20
Additional proxy soliciting materials
4:05pm
S-3ASR
hke7cy
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
xfkit9 huay2a
20 Apr 20
Automatic shelf registration
4:55pm